(Q37945265)

25 August 2017

title

A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer (English)

1 reference

25 August 2017

1 reference

1 reference

Trevor J Bayliss

1

1 reference

25 August 2017

Jeff T Smith

2

1 reference

25 August 2017

Michael Schuster

3

1 reference

25 August 2017

Konstantin H Dragnev

4

1 reference

25 August 2017

James R Rigas

5

1 reference

25 August 2017

language of work or name

English

0 references

publication date

13 October 2011

1 reference

Expert Opinion on Biological Therapy

25 August 2017

published in

1 reference

25 August 2017

volume

11

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

1663-1668

1 reference

Cancer-related inflammation

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

IL-6 involvement in epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Iron sequestration and anemia of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Hepcidin--a regulator of intestinal iron absorption and iron recycling by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Linking anemia to inflammation and cancer: the crucial role of TNFalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

The anemia of inflammation/malignancy: mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Hepcidin, anaemia, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Erlotinib in lung cancer - molecular and clinical predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.627850

10.1517/14712598.2011.627850

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference